Pharma IQ Glossary: European Medicines Evaluation Agency (EMEA)
European Medicines Evaluation Agency (EMEA) or European Medicines Agency (EMA) is a European agency for the evaluation of medicinal products. From 1995 to 2004, the European Medicines Agency was known as European Agency for the Evaluation of Medicinal Products. The EMA was set up in 1995 with funding from the European Union and the pharmaceutical industry, as well as indirect subsidy from member states, in an attempt to harmonize (but not replace) the work of existing national medicine regulatory bodies.
DIA Presents 10 Global Awards
June 19 by Andrea CharlesThe DIA Global Award winners were announced this morning at the opening plenary session of DIA 2011. Recognised for a range of achievements the winners were:Distinguished Career Award...
Fighting Counterfeit Medicines: What's Next?
March 08 by Andrea CharlesJim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ to discuss pharmaceutical counterfeiting, new EU legislation and EAASM’s recommendations. [inlinead]
Paediatric Investigation Plans: Burden or boost?
July 26 by Helen WinsorThe European Paediatric Medicines Regulation is well into its fourth year. Following early concerns that the challenges of compliance outweighed the benefits of the incentives offered, many new proced...
